CymitQuimica logo

CAS 2212020-52-3

:

GLP-1 receptor agonist 1

Description:
GLP-1 receptor agonist 1, identified by the CAS number 2212020-52-3, is a synthetic peptide that mimics the action of the endogenous glucagon-like peptide-1 (GLP-1). This compound is primarily characterized by its ability to bind to and activate the GLP-1 receptor, which plays a crucial role in glucose metabolism and insulin secretion. As a GLP-1 receptor agonist, it enhances insulin release in response to elevated blood glucose levels, promotes satiety, and inhibits glucagon secretion, thereby contributing to glucose homeostasis. Additionally, it may aid in weight management by reducing appetite. The pharmacological profile of GLP-1 receptor agonists typically includes a favorable safety and tolerability profile, although potential side effects can include gastrointestinal disturbances. This class of compounds is of significant interest in the treatment of type 2 diabetes and obesity, as they offer a novel mechanism for managing these conditions. Overall, GLP-1 receptor agonist 1 represents a promising therapeutic agent in metabolic disease management.
Synonyms:
  • 1,2,4-Oxadiazol-5(2H)-one, 3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcy...
  • LY3502970
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.